SK RESEARCH AND DEVELOPMENT, LLC – Trademark Portfolio
Entity Type: 16
SK RESEARCH AND DEVELOPMENT, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IMPACT and INJECT. The owner is based in CHICAGO, IL.
ONE N. FRANKLIN STREET
SUITE 2420
CHICAGO, IL 60606
Showing of trademarks Trademarks
Trademark Classifications
SK RESEARCH AND DEVELOPMENT, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does SK RESEARCH AND DEVELOPMENT, LLC have?
SK RESEARCH AND DEVELOPMENT, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 3 cancelled.
What trademark classes does SK RESEARCH AND DEVELOPMENT, LLC file in?
SK RESEARCH AND DEVELOPMENT, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SK RESEARCH AND DEVELOPMENT, LLC's most well-known trademarks?
SK RESEARCH AND DEVELOPMENT, LLC's registered trademark portfolio includes well-known marks such as IMPACT and INJECT. These are among 2 currently registered trademarks in the portfolio.
What is SK RESEARCH AND DEVELOPMENT, LLC's trademark registration success rate?
SK RESEARCH AND DEVELOPMENT, LLC has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.